APA استشهاد

Kobayashi, K., Sasaki, N., Saito, K., Yamagishi, Y., Matsumoto, Y., Sasaki, Y., . . . Nagane, M. (2020). ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma. Neurooncol Adv.

استشهاد بنمط شيكاغو

Kobayashi, Keiichi, Nobuyoshi Sasaki, Kuniaki Saito, Yuki Yamagishi, Yoshie Matsumoto, Yuta Sasaki, Saki Shimizu, Yoshiaki Shiokawa, و Motoo Nagane. "ML-21 Tirabrutinib Monotherapy for Relapsed/refractory Primary Central Nervous System Lymphoma." Neurooncol Adv 2020.

MLA استشهاد

Kobayashi, Keiichi, et al. "ML-21 Tirabrutinib Monotherapy for Relapsed/refractory Primary Central Nervous System Lymphoma." Neurooncol Adv 2020.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.